FDA Announces Public Advisory Committee Meeting for Pediatric and Endocrinologic Drugs

Summary

The Food and Drug Administration (FDA) is hosting a public advisory committee meeting for the Pediatric Advisory Committee (PAC) and the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC), with at least one portion closed to the public, to provide advice on regulatory issues related to pediatric and endocrinologic drugs.